Listed

Leidos Holdings, Inc.: Form 10-Q for the period ended Jul 3, 2020

Filed with the SEC on Aug 4, 2020 and accepted by EDGAR at Aug 4, 2020, 13:18 ET.

Share

Management's discussion and analysis

As filed, 31,855 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of Leidos Holdings, Inc.'s ("Leidos") financial condition, results of operations, and quantitative and qualitative discussion about business environment and trends should be read in conjunction with Leidos' condensed consolidated financial statements and related notes.

The following discussion contains forward-looking statements, including statements regarding our intent, belief or current expectations with respect to, among other things, trends affecting our financial condition or results of operations, backlog, our industry, the impact of our merger and acquisition activity, government budgets and spending, our business contingency plans and our ability to recover certain costs through the Coronavirus Aid, Relief and Economic Security Act ("CARES Act"). Such statements are not guarantees of future performance and involve risks and uncertainties, including uncertainties relating to the coronavirus outbreak ("COVID-19") and the actions taken by authorities and us to respond, and actual results may differ materially from those in the forward-looking statements as a result of various factors. Some of these factors include, but are not limited to, the risk factors set forth in our Annual Report on Form 10-K, as updated by the risk factor in this report under Part II, Item 1A. "Risk Factors" and as may be further updated in subsequent filings with the U.S. Securities and Exchange Commission. Due to such uncertainties and risks, you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. We do not undertake any obligation to update these factors or to publicly announce the results of any changes to our forward-looking statements due to future events or developments.

Unless indicated otherwise, references in this report to "we," "us" and "our" refer collectively to Leidos and its consolidated subsidiaries.

Overview

We are a FORTUNE 500® science, engineering and information technology company that provides services and solutions in the defense, intelligence, civil and health markets, both domestically and internationally. We bring domain-specific capability and cross-market innovations to customers in each of these markets by leveraging seven core capabilities: cyber; digital modernization; integrated systems; mission software systems; mission support; operations and logistics; and sensors, collection and phenomenology. Our customers include the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security, the Federal Aviation Administration, the Department of Veterans Affairs and many other U.S. government civilian agencies, state and local government agencies and foreign government agencies. We operate in three reportable segments: Defense Solutions, Civil and Health. Additionally, we separately present the unallocable costs associated with corporate functions as Corporate.

Effective the beginning of fiscal 2020, certain contracts were reassigned from the Civil reportable segment to the Defense Solutions reportable segment. Prior year segment results have been recast to reflect this change.

COVID-19

The COVID-19 outbreak is affecting major economic and financial markets, and effectively all industries and governments are facing challenges, which has resulted in a period of business disruption, the length and severity of which cannot be predicted. The outbreak has resulted in significant travel restrictions, government orders to “shelter-in-place”, quarantine restrictions and significant disruption of the financial markets. We have acted to protect the health and safety of our employees, comply with workplace health and safety regulations and work with our customers to minimize disruptions. The outbreak has impacted each of our groups, primarily in access to customer sites, travel restrictions, limitations of remote work and COVID-19 related costs.

Consistent with federal, state and local guidance, we perform work that is essential to support the critical infrastructure of the United States, the Defense Industrial Base and healthcare sector and we continue to operate in support of our customers. We have taken steps to support increased teleworking and safe workplace environments. We have some minor business operations that are not designated as critical infrastructure and therefore have been required to operate in minimal conditions.

For the three and six months ended July 3, 2020, COVID-19 adversely impacted revenues by approximately $132 million and $153 million, respectively, and impacted operating income for the three and six months ended July 3, 2020 by approximately $68 million and $73 million, respectively, as compared to prior year results. The full extent of the impact of the COVID-19 outbreak on our operational and financial performance, including our ability to execute on programs in the expected timeframe, will depend on future developments, including the duration and spread of the outbreak and related actions taken by the U.S. government, state and local government officials and international governments to prevent disease spread, all of which are uncertain and cannot be predicted. While we have been able to make some recoveries, the ultimate timing and amount of recoveries remain uncertain as they will depend on a range of government actions, including each government agency and/or contracting officer's implementation of the authority granted in Section 3610 of the CARES Act, a $2 trillion coronavirus response bill providing widespread emergency relief, including the availability of funds.

We have experienced delays, and expect to continue experiencing delays, on certain contracts as a result of standby leave absences, which has caused a portion of our contracts to be less profitable. We are seeking reimbursement of some of the COVID-19 related costs under our U.S. government contracts through a combination of equitable adjustments to the contract prices and reimbursement of the costs under Section 3610, which allows, but does not require, federal agencies to reimburse contractors at the minimum applicable contract billing rate for costs arising from certain paid leave, including sick leave, a contractor provides to keep its employees or subcontractors in a ready state, including to protect the life and safety of government and contractor personnel, through September 30, 2020. Reimbursement of any costs under Section 3610 increases sales, but is not expected to include a profit or fee and so would have the effect of reducing our margins in future periods. Standby cost increases, including costs for employees whose jobs cannot be performed remotely, may not be fully recoverable under our contracts, particularly fixed-price contracts, or adequately covered by insurance. We also have no assurance that Congress will appropriate funds to cover the reimbursement of defense contractors authorized by the CARES Act, which could reduce funds available for recovery of these costs or for other U.S. government defense priorities.

The CARES Act also enabled us to defer our federal and some state income tax payments from the second quarter of fiscal 2020 to the third quarter of fiscal 2020 and also to defer payment of the employer portion of social security taxes for the balance of fiscal 2020. For the three and six months ended July 3, 2020, we deferred $48 million of employer social security tax payments and received $10 million from the Employee Retention Credit.

We have taken measures to protect the health and well-being of our workforce and are working with our customers to minimize the delay and disruption of the award and performance on our contracts. Many of our employees continue to work remotely while our offices remain open with limited capacity.

Business Environment and Trends

U.S. Government Markets

During the three and six months ended July 3, 2020, we generated approximately 87% and 88%, respectively, of our total revenues from contracts with the U.S. government. Accordingly, our business performance is affected by the overall level of U.S. government spending, especially on national security, homeland security and intelligence, and the alignment of our service and product offerings and capabilities with current and future budget priorities of the U.S. government.

On February 10, 2020, the President submitted the government fiscal year ("GFY") 2021 budget proposal to Congress, which included discretionary spending levels for defense and non-defense programs of $741 billion and $590 billion, respectively. Congress and the Administration have now shifted their collective attention to mitigating the impact of COVID-19. Consequently, the GFY 2021 budget cycle is delayed and spending levels could be affected, which could impact our business performance.

International Markets

Sales to customers in international markets represented approximately 8% of total revenues for the three and six months ended July 3, 2020. Our international customers include foreign governments and their agencies. Our international business increases our exposure to international markets and the associated international regulatory and geopolitical risks.

Recent changes in international trade policies, including higher tariffs on imported goods and materials, may increase our procurement costs of certain IT hardware used both on our contracts and for internal use. However, we expect to recover certain portions of these higher tariffs through our cost-plus contracts. While we are still evaluating the impact of higher tariffs, currently, we do not expect tariffs to have a significant impact to our business.

Results of Operations

The following table summarizes our condensed consolidated results of operations for the periods presented:

(dollars in millions)

Three Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change Six Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change
Revenues $2,914 $2,728 $186 6.8% $5,803 $5,305 $498 9.4%
Operating income 249 210 39 18.6% 441 402 39 9.7%
Non-operating (expense) income, net (57) (31) (26) 83.9% (119) 23 (142) NM
Income before income taxes 192 179 13 7.3% 322 425 (103) (24.2)%
Income tax expense (38) (41) 3 (7.3)% (53) (98) 45 (45.9)%
Net income 154 138 16 11.6% 269 327 (58) (17.7)%
Net income attributable to Leidos common stockholders $153 $136 $17 12.5% $268 $325 $(57) (17.5)%
Operating margin 8.5% 7.7% 7.6% 7.6%

NM - Not meaningful

Segment and Corporate Results

(dollars in millions)

Defense Solutions Three Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change Six Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change
Revenues $1,757 $1,560 $197 12.6% $3,462 $3,051 $411 13.5%
Operating income 119 113 6 5.3% 214 217 (3) (1.4)%
Operating margin 6.8% 7.2% 6.2% 7.1%

The increase in revenues for the three months ended July 3, 2020, as compared to the three months ended June 28, 2019, was primarily attributable to $206 million of revenues related to the acquisition of Dynetics, Inc. ("Dynetics") and program wins, partially offset by the completion of certain contracts, approximately $18 million of negative impacts from reduced volume on certain contracts due to COVID-19 and adverse exchange rate movements, primarily related to changes in the Australian dollar when compared to the U.S. dollar.

The increase in revenues for the six months ended July 3, 2020, as compared to the six months ended June 28, 2019, was primarily attributable to $335 million of revenues related to the acquisition of Dynetics, program wins and a net increase in volumes on certain programs. This was partially offset by the completion of certain contracts, approximately $33 million of negative impacts from reduced volume on certain contracts due to COVID-19 and adverse exchange rate movements, primarily related to changes in the Australian dollar when compared to the U.S. dollar.

The increase in operating income for the three months ended July 3, 2020, as compared to the three months ended June 28, 2019, was primarily due to lower indirect expenditures and program wins. This was partially offset by a net decrease in program volumes, including approximately $11 million of negative impacts from reduced volume on certain contracts due to COVID-19.

The decrease in operating income for the six months ended July 3, 2020, as compared to the six months ended June 28, 2019, was primarily due to approximately $16 million of negative impacts from reduced volume on certain contracts due to COVID-19 and higher amortization of intangible assets related to the acquisition of Dynetics. This was partially offset by program wins and a net increase in volumes on certain programs.

LEIDOS HOLDINGS, INC.

(dollars in millions)

Civil Three Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change Six Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change
Revenues $758 $667 $91 13.6% $1,412 $1,290 $122 9.5%
Operating income 78 56 22 39.3% 137 114 23 20.2%
Operating margin 10.3% 8.4% 9.7% 8.8%

The increase in revenues for the three months ended July 3, 2020, as compared to the three months ended June 28, 2019, was primarily attributable to $80 million of revenues related to the acquisition of L3Harris Technologies' security detection and automation businesses (the "SD&A Businesses") and program wins, partially offset by the completion of certain contracts and approximately $18 million of negative impacts from reduced volume on certain contracts due to COVID-19.

The increase in revenues for the six months ended July 3, 2020, as compared to the six months ended June 28, 2019, was primarily attributable to program wins, $80 million of revenues related to the acquisition of the SD&A Businesses and a net increase in volumes on certain programs. This was partially offset by the completion of certain contracts, approximately $24 million of negative impacts from reduced volume on certain contracts due to COVID-19 and an $11 million impact from the sale of our commercial cybersecurity business in the first quarter of fiscal 2019.

The increase in operating income for the three and six months ended July 3, 2020, as compared to the three and six months ended June 28, 2019, was primarily due to program wins and income related to the acquisition of the SD&A Businesses.

(dollars in millions)

Health Three Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change Six Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change
Revenues $399 $501 $(102) (20.4)% $929 $964 $(35) (3.6)%
Operating income 1 61 (60) (98.4)% 74 106 (32) (30.2)%
Operating margin 0.3% 12.2% 8.0% 11.0%

The decrease in revenues for the three months ended July 3, 2020, as compared to the three months ended June 28, 2019, was primarily attributable to approximately $96 million related to timing of program execution due to COVID-19, a $26 million impact from the sale of our health staff augmentation business in the third quarter of fiscal 2019 and the completion of certain contracts. This was partially offset by program wins and a $7 million impact from our acquisition of IMX Medical Management Services, Inc. in the third quarter of fiscal 2019.

The decrease in revenues for the six months ended July 3, 2020, as compared to the six months ended June 28, 2019, was primarily attributable to approximately $96 million related to timing of program execution due to COVID-19, a $51 million impact from the sale of our health staff augmentation business in the third quarter of fiscal 2019 and the completion of certain contracts. This was partially offset by a net increase in volumes on certain programs, program wins and an $18 million impact from our acquisition of IMX Medical Management Services, Inc. in the third quarter of fiscal 2019.

The decrease in operating income for the three and six months ended July 3, 2020, as compared to the three and six months ended June 28, 2019, was primarily due to approximately $57 million of negative impacts from reduced volume on certain managed service contracts with fixed cost infrastructures that were impacted by COVID-19 and an $11 million asset impairment charge, partially offset by a net increase in volumes on certain programs.

(dollars in millions)

Corporate Three Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change Six Months Ended July 3, 2020 June 28, 2019 Dollar change Percent change
Operating income (loss) $51 $(20) $71 NM $16 $(35) $51 (145.7)%

NM - Not meaningful

The increase in operating income for the three months ended July 3, 2020, as compared to the three months ended June 28, 2019, was primarily attributable to an $81 million net gain recognized upon the receipt of proceeds related to the VirnetX, Inc. ("VirnetX") legal matter, partially offset by a $14 million increase in acquisition and integration costs.

The increase in operating income for the six months ended July 3, 2020, as compared to the six months ended June 28, 2019, was primarily attributable to an $81 million net gain recognized upon the receipt of proceeds related to the VirnetX legal matter, partially offset by a $23 million increase in acquisition and integration costs and higher litigation costs.

Non-Operating Expense, net

Non-operating expense, net for the three months ended July 3, 2020 was $57 million as compared to non-operating expense, net of $31 million for the three months ended June 28, 2019. The change was primarily due to $12 million of debt discount and deferred financing costs written off related to the refinancing of our bridge facilities and higher interest expense associated with increases in our long-term debt.

Non-operating expense, net for the six months ended July 3, 2020 was $119 million as compared to non-operating income, net of $23 million for the six months ended June 28, 2019. The change was primarily due to the $87 million gain recognized on the sale of our commercial cybersecurity business in the prior year, $31 million of debt discount and deferred financing costs written off related to the refinancing of our term loans and bridge facilities and higher interest expense associated with increases in our long-term debt.

Provision for Income Taxes

For the three months ended July 3, 2020, our effective tax rate was 19.8% compared to 22.9% for the three months ended June 28, 2019. The decrease in the effective tax rate was primarily due to an increase in benefits related to federal research tax credits and a decrease to state income taxes.

For the six months ended July 3, 2020, our effective tax rate was 16.5% compared to 23.1% for the six months ended June 28, 2019. The decrease in the effective tax rate was primarily due to an increase in benefits related to employee stock-based payments, a release of a valuation allowance related to foreign tax credits and higher prior period unrecognized tax benefits.

Bookings and Backlog

We recorded net bookings worth an estimated $4.6 billion and $10.2 billion during the three and six months ended July 3, 2020, respectively, as compared to $3.0 billion and $6.3 billion for the three and six months ended June 28, 2019, respectively.

The estimated value of our total backlog was as follows:

(in millions)

Defense Solutions: July 3, 2020 January 3, 2020
Funded backlog $4,275 $3,063
Negotiated unfunded backlog 13,779 11,974
Total Defense Solutions backlog $18,054 $15,037
Civil:
Funded backlog $1,695 $1,267
Negotiated unfunded backlog 6,634 2,978
Total Civil backlog $8,329 $4,245
Health:
Funded backlog $1,074 $1,083
Negotiated unfunded backlog 3,204 3,725
Total Health backlog $4,278 $4,808
Total:
Funded backlog $7,044 $5,413
Negotiated unfunded backlog 23,617 18,677
Total backlog $30,661 $24,090

33

The change in backlog for the Defense Solutions and Civil reportable segments reflect $1,762 million and $574 million, respectively, of backlog acquired as a result of the acquisitions of Dynetics and the SD&A Businesses, respectively.

Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts, both funded and unfunded. Backlog does not include unexercised option periods and future potential task orders expected to be awarded under indefinite delivery/indefinite quantity ("IDIQ"), General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded and separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future task orders is anticipated. Total backlog at July 3, 2020 included an adverse impact of $129 million when compared to total backlog at January 3, 2020, due to exchange rate movements in the British pound and Australian dollar when compared to the U.S. dollar. Backlog estimates are subject to change and may be affected by factors including modifications of contracts and foreign currency movements.

Liquidity and Capital Resources

Overview

As of July 3, 2020, we had $588 million in cash and cash equivalents. In January 2020, we entered into an unsecured revolving credit facility which can provide up to $750 million in additional borrowing, if required. This new credit facility replaced the previous secured credit facility with the same borrowing capacity. As of July 3, 2020, there were no borrowings outstanding under the credit facility and we were in compliance with the related financial covenants.

At July 3, 2020, and January 3, 2020, we had outstanding debt of $5.0 billion and $3.0 billion, respectively. In January 2020, we entered into a Credit Agreement with certain financial institutions, which provided for a senior unsecured term loan facility in an aggregate principal amount of $1.9 billion (the "Term Loan Facility"). We used the proceeds of the Term Loan Facility and cash on hand to repay in full all indebtedness, and terminate all commitments, under, and discharge and release all guarantees and liens existing in connection with the credit agreements entered into in August 2016.

Additionally, on January 17, 2020, we entered into a Bridge Credit Agreement with certain financial institutions, which provided for a senior unsecured 364-day bridge loan facility in an aggregate amount of $1.25 billion (the "Bridge Facility"). We used the proceeds of the Bridge Facility and cash on hand to fund the purchase of Dynetics and repay in full all third party indebtedness of Dynetics, terminate all commitments thereunder and discharge and release all existing guarantees and liens.

In February 12, 2020, we entered into a senior unsecured delayed-draw term loan facility (the "Facility") providing for $1.0 billion of commitments from certain financial institutions in connection with the acquisition of the SD&A Businesses. On May 4, 2020, we completed our acquisition of the SD&A Businesses and drew on the Facility in an aggregate principal amount of $1.0 billion. The proceeds of the Facility and cash on hand were used to fund the purchase of the SD&A Businesses.

On May 12, 2020, we issued and sold $500 million senior notes maturing in May 2023, $500 million senior notes maturing in May 2025 and $750 million senior notes maturing in May 2030 (collectively, the "Notes"). The proceeds from the Notes were used to repay all of the outstanding obligations in respect of principal, interest, fees and other amounts under the Bridge Credit Agreement and to repay a portion of the outstanding loans under the Facility.

On June 18, 2020, we entered into a 364-day Term Loan Credit Agreement, which provided for a senior unsecured term loan facility in an aggregate principal amount of $300 million (the "Term Loan"). The proceeds of the Term Loan and cash on hand on were used to repay in full all indebtedness under, and discharge and release all guarantees existing in connection with the Facility.

See "Note 10–Debt" for further details regarding the debt transactions noted above.

In addition to the refinancing activity noted above, we made principal payments on our long-term debt of $226 million and $228 million during the three and six months ended July 3, 2020, respectively, and $17 million and $48 million during the three and six months ended June 28, 2019, respectively. This activity included required principal payments on our term loans of $24 million during the three months ended July 3, 2020 and $14 million and $41 million during the three and six months ended June 28, 2019, respectively. The senior unsecured term loans and notes contain financial covenants and customary restrictive covenants. We were in compliance with all covenants as of July 3, 2020.

We paid dividends of $48 million and $99 million during the three and six months ended July 3, 2020, respectively, and $47 million and $101 million during the three and six months ended June 28, 2019, respectively.

During the three and six months ended July 3, 2020, we sold $549 million and $1,113 million, respectively, of accounts receivable under accounts receivable purchase agreements and received proceeds of $549 million and $1,112 million, respectively (see "Note 13–Supplementary Cash Flow Information and Restricted Cash").

COVID-19 has negatively impacted the financial markets and may impact our liquidity; we will continue to assess our liquidity needs as the outbreak evolves.

For the next 12 months, we anticipate that we will be able to meet our liquidity needs, including servicing our debt, through cash generated from operations, available cash balances, sales of accounts receivable and, if needed, borrowings under our revolving credit facility.

Summary of Cash Flows

The following table summarizes cash flow information for the periods presented:

(in millions)

Three Months Ended July 3, 2020 June 28, 2019 Six Months Ended July 3, 2020 June 28, 2019
Net cash provided by operating activities $422 $186 $794 $474
Net cash (used in) provided by investing activities (1,014) (16) (2,699) 221
Net cash provided by (used in) financing activities 709 (64) 1,870 (361)
Net increase (decrease) in cash, cash equivalents and restricted cash $117 $106 $(35) $334

Net cash provided by operating activities increased $236 million for the three months ended July 3, 2020, when compared to the prior year quarter. The increase was primarily due to the timing of advance payments from customers, the receipt of $85 million of proceeds related to the VirnetX legal matter, lower tax payments, partially related to the CARES Act, and the sale of accounts receivable in the last month of the quarter. This was partially offset by the timing of payroll payments.

Net cash provided by operating activities increased $320 million for the six months ended July 3, 2020, when compared to the prior year. The increase was primarily due to the sale of accounts receivable in the last month of the quarter, the receipt of $85 million of proceeds related to the VirnetX legal matter, lower tax payments, partially related to the CARES Act, and favorable working capital changes. This was partially offset by higher advance payments from customers in the prior year.

Net cash used in investing activities increased $998 million for the three months ended July 3, 2020, when compared to the prior year quarter, primarily due to $968 million of net cash paid related to the acquisition of the SD&A Businesses.

Net cash used in investing activities increased $2,920 million for the six months ended July 3, 2020, when compared to the prior year, primarily due to $2,610 million of net cash paid related to the acquisitions of Dynetics and the SD&A Businesses and $267 million received in the prior year for the disposition of our commercial cybersecurity business and sale of real estate properties.

Net cash provided by financing activities increased $773 million for the three months ended July 3, 2020, when compared to the prior year quarter, primarily due to $3,050 million of proceeds received related to the issuance of debt, partially offset by $2,050 million of principal payments related to refinancing of outstanding debt and $200 million of additional principal payments on our outstanding debt in the current quarter.

Net cash provided by financing activities increased $2,231 million for the six months ended July 3, 2020, when compared to the prior year, primarily due to $6,225 million of proceeds received related to the issuance of debt and $200 million of stock repurchases in the prior year. This was partially offset by $3,975 million of principal payments related to refinancing of outstanding debt and $200 million of additional principal payments on our outstanding debt in the current year.

Off-Balance Sheet Arrangements

We have outstanding performance guarantees and cross-indemnity agreements in connection with certain aspects of our business. We also have letters of credit outstanding principally related to performance guarantees on contracts and surety bonds outstanding principally related to performance and subcontractor payment bonds as described in "Note 16–Commitments" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q. These arrangements have not had, and management does not believe it is likely that they will in the future have, a material effect on our liquidity, capital resources, operations or financial condition.

Commitments and Contingencies

We are subject to a number of reviews, investigations, claims, lawsuits, other uncertainties and future obligations related to our business. For a discussion of these items, see "Note 15–Contingencies" and "Note 16–Commitments" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q.

Critical Accounting Policies

There were no material changes to our critical accounting policies, estimates or judgments during the period covered by this report from those discussed in our Annual Report on Form 10-K for the year ended January 3, 2020.

Recently Adopted and Issued Accounting Standards

For a discussion of these items, see "Note 1–Basis of Presentation and Summary of Significant Accounting Policies" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q.

Market risk

As filed, 369 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The broad effects of the COVID-19 outbreak have resulted in negative impacts on the global economy and financial markets and may affect our interest rates and cause foreign currency fluctuations.

Except as noted above, there were no material changes in our market risk exposure from those discussed in our Annual Report on Form 10-K for the year ended January 3, 2020.

Controls and procedures

As filed, 2,135 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer (our Chairman and Chief Executive Officer) and principal financial officer (our Executive Vice President and Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934) as of July 3, 2020. Based upon that evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission. These disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

On January 31, 2020 and May 4, 2020, we completed the acquisitions of Dynetics and the SD&A Businesses, respectively. In conducting our evaluation of the effectiveness of our internal control over financial reporting, we excluded Dynetics and the SD&A Businesses from our evaluation for the second quarter of fiscal 2020. We are in the process of integrating Dynetics and the SD&A Businesses into our system of internal control over financial reporting.

Other than the foregoing, there have been no changes in our internal control over financial reporting that occurred in the quarterly period covered by this report that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 4,033 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Other than as described below, there have been no material changes to the risks described in Part I, Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended January 3, 2020 and Part II, Item 1A “Risk Factors” in our Quarterly Report on Form 10-Q for the quarterly period ended April 3, 2020. If any risks and uncertainties described below actually occur, our business, financial condition or operating results could be materially harmed and the price of our stock could decline. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may materially harm our business.

The extent to which our business will be adversely affected by the recent COVID-19 outbreak or other health epidemics, pandemics and similar outbreaks is highly uncertain and cannot be predicted.

The recent outbreak and global spread of COVID-19, and the preventative or protective actions that governments, corporations, individuals and we are taking and may continue to take in an effort to limit the impact of COVID-19, have resulted in a period of business disruption and increased economic uncertainty. The spread of COVID-19 has caused us to modify our business practices (including employee travel, access to customer sites, employee and contractor remote work and cancellation of physical participation in meetings, events and conferences), and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers and business partners. There is no certainty that such measures will be sufficient to mitigate the risks posed by COVID-19 or otherwise be satisfactory to government authorities. If significant portions of our workforce are unable to work effectively, including because of illness, quarantines, government actions, facility closures or other restrictions due to COVID-19, our operations and results will likely be impacted.

Government agencies are our primary customers and the long-term impact of increased government spending in response to COVID-19 is uncertain. For example, the U.S. government fiscal year 2021 budget cycle will likely be delayed as the U.S. government focuses its attention on mitigating the impact of COVID-19, which could result in a re-evaluation of U.S. government spending levels and priorities. Even after COVID-19 has subsided, we may experience materially adverse impacts on our business as a result of the outbreak's global economic impact, including any recession that is occurring or may occur in the future. New contract awards have been and may continue to be delayed and our ability to perform on our existing contracts had been and may continue to be delayed or impaired, which will negatively impact our revenues. In addition, our costs may increase as a result of COVID-19, and these cost increases may not be fully recoverable or adequately covered by insurance, which could impact our profitability. The continued spread of COVID-19 has had and may continue to have similar negative impacts on our customers, subcontractors and suppliers, causing delay or limiting their ability to perform, including in making timely payments to us. Any resulting financial impact cannot be reasonably estimated at this time but may materially and adversely affect our business, financial condition, results of operations and cash flows. The extent to which COVID-19 impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity and duration of COVID-19 and actions to contain it or treat its impact, among others. In addition, to the extent COVID-19 or any worsening of the global business and economic environment as a result adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described under Part I, Item 1A "Risk Factors" of our most recent Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-07-03. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-04 to 2020-07-03$2.89bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-04 to 2020-07-03$5.76bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-04-04 to 2020-07-03$2.53bnus-gaap:CostOfRevenue
Cost of revenue6 months2020-01-04 to 2020-07-03$5.03bnus-gaap:CostOfRevenue
Selling, general and administrative3 months2020-04-04 to 2020-07-03$195.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-04 to 2020-07-03$383.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-04-04 to 2020-07-03$249.0mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-04 to 2020-07-03$441.0mus-gaap:OperatingIncomeLoss
Income tax3 months2020-04-04 to 2020-07-03$38.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-04 to 2020-07-03$53.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-04-04 to 2020-07-03$153.0mus-gaap:NetIncomeLoss
Net income6 months2020-01-04 to 2020-07-03$268.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-04 to 2020-07-03$1.06us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-01-04 to 2020-07-03$1.86us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-04-04 to 2020-07-03$1.08us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-01-04 to 2020-07-03$1.89us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-04-04 to 2020-07-03144,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-01-04 to 2020-07-03144,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-01-04 to 2020-07-03$794.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-04 to 2020-07-03$90.0mus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2020-07-03$588.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-07-03$3.05bnus-gaap:AssetsCurrent
Total assetsAt period end2020-07-03$12.14bnus-gaap:Assets
Current liabilitiesAt period end2020-07-03$3.43bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2020-07-03$854.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2020-07-03$3.54bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001336920-20-000069. Last ingested by Listed: Nov 3, 2026, 11:59 ET. Listed shows no prices and gives no investment advice.